Meijie Wang is the co-founder and CEO of MetaNovas, an AI-driven biotech that designs functional peptides for skincare, supplements and drug discovery. A former NVIDIA AI infrastructure engineer who built VR games and worked on AI at Stanford's School of Medicine, he now runs a Silicon Valley and Shanghai operation whose knowledge-graph platform aims to compress the decade-long hunt for new bioactive ingredients into something far shorter. MetaNovas counts L'Oreal, Beiersdorf, Haleon, Takeda and Unilever among its partners and raised a Series A led by GL Ventures.
Biohm Technologies is a Cleveland-based microbiome innovation company that studies the gut as a whole - bacteria and fungi together - rather than bacteria alone. Built on 40+ years of fungal research by Dr. Mahmoud Ghannoum, the scientist who named the mycobiome, Biohm develops data-driven biotic ingredients and gut-health testing solutions. Its flagship ingredient Mycohsa is the first probiotic blend clinically shown to break down digestive biofilms, and its Symbiont discovery platform mines a large bacterial-fungal dataset to design targeted microbiome products. After a B2B pivot in 2024, the company now sells ingredients and microbiome science to nutraceutical and food brands.